Calocurb should not be taken by individuals that have any form of gastrointestinal inflammation or inflammatory bowel disease, such as Crohns or ulcerative colitis
The studys limitations include residual confounding, unexplored dose-response relationships, lack of age stratification, and limited adjustment for multiple testing
Even more people have nutrient inadequacies---when intake of a nutrient is above the level usually associated with deficiency but below the estimated average requirement for healthy individuals---suggesting a potential for marginal deficiencies
Leiter LA, Bain SC, Hramiak I, et al
We believe in a personalized approach to healthcare
Importantly, only certain formulations are FDA-approved for chronic weight managementspecifically Wegovy (semaglutide) and Zepbound (tirzepatide)while Ozempic and Mounjaro are approved for type 2 diabetes management only